FDA
label_change
· 2011-05-31
FDA Approved: EXFORGE — Supplemental Application (Novartis Pharmaceuticals Corporation)
Summary
The FDA approved a supplemental application for EXFORGE (amlodipine besylate and valsartan) by Novartis Pharmaceuticals Corporation. The action updates the prod…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for EXFORGE (AMLODIPINE BESYLATE AND VALSARTAN)